Marme, F., Hanusch, C., Furlanetto, J., Denkert, C., Link, T., Untch, M., Blohmer, J-U., Jackisch, C., Reinisch, M., Rhiem, K. E., Schneeweiss, A., Solbach, C., Schoellhorn, L., Fasching, P. A., Rey, J. and Loibl, S. (2021). Phase III post-neoadjuvant study evaluating sacituzumab govitecan (SG), an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA. Ann. Oncol., 32. S. S443 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Marme, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hanusch, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Furlanetto, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Denkert, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Link, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Untch, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Blohmer, J-U.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jackisch, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Reinisch, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rhiem, K. E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schneeweiss, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Solbach, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schoellhorn, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fasching, P. A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rey, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Loibl, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-603407
DOI: 10.1016/j.annonc.2021.08.480
Journal or Publication Title: Ann. Oncol.
Volume: 32
Page Range: S. S443 - 2
Date: 2021
Publisher: ELSEVIER
Place of Publication: AMSTERDAM
ISSN: 1569-8041
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/60340

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item